351
Views
39
CrossRef citations to date
0
Altmetric
Articles

VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells

, , , , &
Pages 306-317 | Received 12 Jan 2010, Accepted 07 Apr 2010, Published online: 24 May 2010

References

  • Attal J, Theron MC, Houdebine LM. 1999. The optimal use of IRES (internal ribosome entry site) in expression vectors. Genet Anal. 15:161–165.
  • Botchwey EA, Pollack SR, Levine EM, Laurencin CT. 2001. Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J Biomed Mater Res. 55:242–253.
  • Botchwey EA, Dupree MA, Pollack SR, Levine EM, Laurencin CT. 2003. Tissue engineered bone: Measurement of nutrient transport in three-dimensional matrices. J Biomed Mater Res A. 67:357–367.
  • Cui Q, Xiao Z, Li X, Saleh KJ, Balian G. 2006. Use of genetically engineered bone-marrow stem cells to treat femoral defects: An experimental study. J Bone Joint Surg Am. 88 Suppl 3: 167–172.
  • Desmyter S, Goubau Y, Benahmed N, de Wever A, Verdonk R. 2008. The role of bone morphogenetic protein-7 (Osteogenic Protein-1) in the treatment of tibial fracture non-unions. An overview of the use in Belgium. Acta Orthop Belg. 74:534–537.
  • Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. 2005. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury. 36 Suppl 4: S51–S59.
  • Dohin B, Dahan-Oliel N, Fassier F, Hamdy R. 2009. Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): Early experience. Clin Orthop Relat Res. 467:3230–3238.
  • Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I. 2005. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br. 87:1434–1438.
  • Fiedler J, Roderer G, Gunther KP, Brenner RE. 2002. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem. 87:305–312.
  • Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE. 2005. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun. 334:561–568.
  • Friedman MS, Long MW, Hankenson KD. 2006. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem. 98:538–554.
  • Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Richter W. 2005. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res. 20:2028–2035.
  • Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 5:623–628.
  • Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T, BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 84-A:2123–2134.
  • Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B. 2001. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem. 81:284–294.
  • Hansen-Algenstaedt N, Joscheck C, Wolfram L, Schaefer C, Muller I, Bottcher A, Deuretzbacher G, Wiesner L, Leunig M, Algenstaedt P, Ruther W. 2006. Sequential changes in vessel formation and micro-vascular function during bone repair. Acta Orthop. 77:429–439.
  • Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ. 2005. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res. 20:848–857.
  • Jabbarzadeh E, Starnes T, Khan YM, Jiang T, Wirtel AJ, Deng M, Lv Q, Nair LS, Doty SB, Laurencin CT. 2008. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA. 105:11099–11104.
  • Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. 1988. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol. 62:2636–2643.
  • Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH. 2006. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res. 21:735–744.
  • Kanczler JM, Ginty PJ, Barry JJ, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO. 2008. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials. 29:1892–1900.
  • Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO. 2010. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials. 31:1242–1250.
  • Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He TC. 2004. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 11:1312–1320.
  • Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. 2009. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 30:2816–2825.
  • Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA. 2003. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther. 10:1735–1743.
  • Martinez-Salas E. 1999. Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol. 10:458–464.
  • Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE. 2002. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone. 30:472–477.
  • Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9–22.
  • Newman KD, McBurney MW. 2004. Poly(d,l lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. Biomaterials. 25:5763–5771.
  • Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. 2007. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun. 354:453–458.
  • Pelletier J, Sonenberg N. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:320–325.
  • Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 110:751–759.
  • Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J. 2005. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 20:2017–2027.
  • Probst A, Spiegel HU. 1997. Cellular mechanisms of bone repair. J Invest Surg. 10:77–86.
  • Pufe T, Petersen W, Tillmann B, Mentlein R. 2001. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum. 44:1082–1088.
  • Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. 2008. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci. 108:18–31.
  • Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P. 2007. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci. 120:964–972.
  • Street J, Lenehan B. 2009. Vascular endothelial growth factor regulates osteoblast survival – evidence for an autocrine feedback mechanism. J Orthop Surg Res. 4:19.
  • Street J, Bao M, deGuzman L, Bunting S, Peale FVJr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. 99:9656–9661.
  • Tatsuyama K, Maezawa Y, Baba H, Imamura Y, Fukuda M. 2000. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem. 44:269–278.
  • Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T. 2003. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone. 32:491–501.
  • Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE. 2002. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res. 395:110–120.
  • Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P. 1990. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA. 87:2220–2224.
  • Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, Lovejoy S, D'Amore PA, Olsen BR. 2002. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development. 129:1893–1904.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.